The Clinical and Prognostic Significance of Activated AKT-mTOR Pathway in Human Astrocytomas.
about
A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057KThe challenges and the promise of molecular targeted therapy in malignant gliomas.Ultrastructural characterization of the Mitochondria-associated membranes abnormalities in human astrocytomas: Functional and therapeutics implications.
P2860
The Clinical and Prognostic Significance of Activated AKT-mTOR Pathway in Human Astrocytomas.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The Clinical and Prognostic Si ...... Pathway in Human Astrocytomas.
@ast
The Clinical and Prognostic Si ...... Pathway in Human Astrocytomas.
@en
type
label
The Clinical and Prognostic Si ...... Pathway in Human Astrocytomas.
@ast
The Clinical and Prognostic Si ...... Pathway in Human Astrocytomas.
@en
prefLabel
The Clinical and Prognostic Si ...... Pathway in Human Astrocytomas.
@ast
The Clinical and Prognostic Si ...... Pathway in Human Astrocytomas.
@en
P2093
P2860
P356
P1476
The Clinical and Prognostic Si ...... Pathway in Human Astrocytomas.
@en
P2093
Aggeliki A Saetta
Christina Piperi
Christos Adamopoulos
Elias A El Habr
Georgia Levidou
Penelope Korkolopoulou
P2860
P304
P356
10.1155/2012/454957
P577
2012-02-21T00:00:00Z